RECURSION PHARMACEUTICALS, INC. financial data

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 443% % -1.6%
Debt-to-equity 36% % -5%
Return On Equity -64% % 12%
Return On Assets -47% % 11%
Operating Margin -868% % -6.6%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 528,182,693 shares 33%
Entity Public Float $2,030,000,000 USD 35%
Common Stock, Value, Issued $5,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 447,446,109 shares 63%
Weighted Average Number of Shares Outstanding, Diluted 447,446,109 shares 63%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $74,681,000 USD 27%
Research and Development Expense $475,271,000 USD 51%
General and Administrative Expense $176,589,000 USD -0.9%
Costs and Expenses $722,813,000 USD 34%
Operating Income (Loss) $648,132,000 USD -35%
Nonoperating Income (Expense) $3,237,000 USD -77%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $644,895,000 USD -39%
Income Tax Expense (Benefit) $136,000 USD 88%
Net Income (Loss) Attributable to Parent $644,759,000 USD -39%
Earnings Per Share, Basic -1.44 USD/shares 15%
Earnings Per Share, Diluted -1.44 USD/shares 15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $743,294,000 USD 25%
Other Assets, Current $28,566,000 USD -25%
Assets, Current $812,845,000 USD 14%
Deferred Income Tax Assets, Net $957,000 USD -51%
Property, Plant and Equipment, Net $103,931,000 USD -26%
Operating Lease, Right-of-Use Asset $45,339,000 USD -31%
Intangible Assets, Net (Excluding Goodwill) $309,903,000 USD -7.7%
Goodwill $162,158,000 USD 8.9%
Other Assets, Noncurrent $12,754,000 USD 45%
Assets $1,474,130,000 USD 1.8%
Accounts Payable, Current $18,118,000 USD -16%
Employee-related Liabilities, Current $31,771,000 USD -38%
Accrued Liabilities, Current $70,230,000 USD -14%
Contract with Customer, Liability, Current $37,605,000 USD -39%
Liabilities, Current $147,707,000 USD -21%
Long-term Debt and Lease Obligation $9,564,000 USD -50%
Contract with Customer, Liability, Noncurrent $114,012,000 USD -4%
Deferred Income Tax Liabilities, Net $23,255,000 USD 40%
Operating Lease, Liability, Noncurrent $46,647,000 USD -31%
Other Liabilities, Noncurrent $2,080,000 USD -56%
Liabilities $343,265,000 USD -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $36,717,000 USD
Retained Earnings (Accumulated Deficit) $2,076,002,000 USD -45%
Stockholders' Equity Attributable to Parent $1,130,865,000 USD 9.3%
Liabilities and Equity $1,474,130,000 USD 1.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $131,957,000 USD -29%
Net Cash Provided by (Used in) Financing Activities $40,527,000 USD 192%
Net Cash Provided by (Used in) Investing Activities $7,270,000 USD -9.3%
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 528,182,693 shares 33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $93,867,000 USD 1.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $753,921,000 USD 25%
Deferred Tax Assets, Valuation Allowance $665,371,000 USD 43%
Deferred Tax Assets, Gross $719,596,000 USD 33%
Operating Lease, Liability $59,310,000 USD -27%
Depreciation $18,300,000 USD 15%
Payments to Acquire Property, Plant, and Equipment $1,832,000 USD -72%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $600,405,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid $72,683,000 USD -28%
Property, Plant and Equipment, Gross $193,145,000 USD -5.2%
Operating Lease, Liability, Current $12,663,000 USD -8.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $17,827,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year One $17,467,000 USD -9.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.079 pure 2.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13,373,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $15,171,000 USD -27%
Deferred Tax Assets, Operating Loss Carryforwards $445,440,000 USD 62%
Unrecognized Tax Benefits $11,803,000 USD 75%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,201,000 USD -51%
Operating Lease, Payments $5,265,000 USD 33%
Additional Paid in Capital $3,170,145,000 USD 28%
Amortization of Intangible Assets $50,300,000 USD 168%
Depreciation, Depletion and Amortization $19,331,000 USD 162%
Deferred Tax Assets, Net of Valuation Allowance $54,225,000 USD -28%
Share-based Payment Arrangement, Expense $110,018,000 USD 38%
Interest Expense $98,000 USD 63%